Seoul, South Korea

Jong-Ik Hwang

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2022

where 'Filed Patents' based on already Granted Patents

3 patents (USPTO):

Title: **Innovator Jong-Ik Hwang: Pioneering Advances in Galanin Receptor Therapeutics**

Introduction

Jong-Ik Hwang, an accomplished inventor based in Seoul, South Korea, has made significant contributions to the field of medical therapeutics. With a portfolio of three patents, Hwang is recognized for his groundbreaking research and innovative inventions that aim to address various physiological challenges.

Latest Patents

One of Hwang's most recent patents is titled "Agonist of Spexin-Based Galanin Type 2 Receptor and Use Thereof." This invention focuses on peptide-based agonists that demonstrate high specificity for the galanin receptor type 2. These agonists not only boast improved stability but are also involved in crucial physiological regulatory functions, such as food intake, anxiety, emotion, and addiction. By effectively suppressing appetite and aiding recovery from anxiety disorders, these peptide-based agonists hold potential for treating diseases related to galanin receptor type 2, showcasing Hwang's impact on medical science.

Career Highlights

Throughout his career, Jong-Ik Hwang has been associated with notable companies like Neuracle Science Co., Ltd. and Anygen Co., Ltd. His work at these organizations has allowed him to collaborate on critical advancements in therapeutic innovations, further solidifying his reputation as a leading inventor in his field.

Collaborations

In his quest for innovation, Hwang has worked alongside esteemed colleagues such as Jae Young Seong and Dong-Hoon Kim. Their collaborative efforts have enriched the research environment, fostering groundbreaking developments in the life sciences and enhancing the potential applications of their inventions.

Conclusion

Jong-Ik Hwang stands as a testament to the power of innovation in addressing complex physiological issues. His contributions through patents and collaborations continue to pave the way for future advancements, promising new solutions for medical challenges associated with galanin receptor types. As research evolves, Hwang's insights and inventions are likely to play an increasingly vital role in therapeutic developments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…